Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.

Afisi S Ismaila Kieran J Rothnie Robert P Wood Victoria L Banks Lucinda J Camidge Alexandrosz Czira Chris ComptonRaj SharmaShannon N MillardOlivia MasseyDavid M G Halpin

Published in: Respiratory research (2023)

Prompt initiation of FF/UMEC/VI following a moderate/severe exacerbation was associated with fewer subsequent exacerbations, fewer hospital readmissions, and lower COPD-related medical costs compared with delayed initiation.

Keyphrases

chronic obstructive pulmonary disease
lung function
healthcare
early onset
intensive care unit
respiratory failure